Abstract
Toll-like receptors (TLR) are crucial components in the initiation of innate immune responses to a variety of pathogens, triggering the production of pro-inflammatory cytokines and type I and II interferons, which are responsible for innate antiviral responses. Among the different TLRs, TLR7 recognizes several single-stranded RNA viruses including SARS-CoV-2. We and others identified rare loss-of-function variants in X-chromosomal TLR7 in young men with severe COVID-19 and with no prior history of major chronic diseases, that were associated with impaired TLR7 signaling as well as type I and II IFN responses. Here, we performed RNA sequencing to investigate transcriptome variations following imiquimod stimulation of peripheral blood mononuclear cells isolated from patients carrying previously identified hypomorphic, hypofunctional, and loss-of-function TLR7 variants. Our investigation revealed a profound impairment of the TLR7 pathway in patients carrying loss-of-function variants. Of note, a failure in IFNγ upregulation following stimulation was also observed in cells harboring the hypofunctional and hypomorphic variants. We also identified new TLR7 variants in severely affected male patients for which a functional characterization of the TLR7 pathway was performed demonstrating a decrease in mRNA levels in the IFNα, IFNγ, RSAD2, ACOD1, IFIT2, and CXCL10 genes.
Highlights
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], has rapidly developed into a global pandemic of enormous consequences
TLR7 stimulation induced a strong response in healthy donors (HDs) with 211 genes significantly upregulated (log2 fold change (FC) ≥ 1.5; adjusted p value ≤ 0.05) and 19 downregulated genes compared with unstimulated peripheral blood mononuclear cells (PBMC)
RNAseq analysis in patients carrying LOF variants showed that none had genes with an adjusted p value ≤ 0.05 (Fig. 1C), suggesting a profound impairment of the TLR7 pathway
Summary
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], has rapidly developed into a global pandemic of enormous consequences. To gain insight into TLR7-linked mechanisms of severe COVID19, we performed RNA sequencing (RNA-Seq) to carefully characterize transcriptome variations following IMQ stimulation of peripheral blood mononuclear cells (PBMC) isolated from patients carrying previously identified LOF TLR7 variants [5]. We found new TLR7 variants in severely affected males for which functional characterization of the pathway was performed.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have